These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7585013)

  • 1. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury.
    Lichtenberger LM; Wang ZM; Romero JJ; Ulloa C; Perez JC; Giraud MN; Barreto JC
    Nat Med; 1995 Feb; 1(2):154-8. PubMed ID: 7585013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advent of novel phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs with improved gastrointestinal safety.
    Lim YJ; Dial EJ; Lichtenberger LM
    Gut Liver; 2013 Jan; 7(1):7-15. PubMed ID: 23423874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine.
    Lichtenberger LM; Zhou Y; Jayaraman V; Doyen JR; O'Neil RG; Dial EJ; Volk DE; Gorenstein DG; Boggara MB; Krishnamoorti R
    Biochim Biophys Acta; 2012 Jul; 1821(7):994-1002. PubMed ID: 22521764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs).
    Giraud MN; Motta C; Romero JJ; Bommelaer G; Lichtenberger LM
    Biochem Pharmacol; 1999 Feb; 57(3):247-54. PubMed ID: 9890551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.
    Griffin MR
    Am J Med; 1998 Mar; 104(3A):23S-29S; discussion 41S-42S. PubMed ID: 9572317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes.
    Lichtenberger LM; Zhou Y; Dial EJ; Raphael RM
    J Pharm Pharmacol; 2006 Nov; 58(11):1421-8. PubMed ID: 17132203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Induced Dyspepsia.
    Yap PR; Goh KL
    Curr Pharm Des; 2015; 21(35):5073-81. PubMed ID: 26369685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in managing NSAID-associated gastrointestinal tract injury.
    Goldstein JL
    Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury.
    Dajani EZ; Agrawal NM
    Int J Clin Pharmacol Res; 1989; 9(6):359-69. PubMed ID: 2699464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sucrose permeability as a marker for nonsteroidal anti-inflammatory gastroduodenal injury: how sweet is it?
    DeMeo M
    Nutr Rev; 1995 Jan; 53(1):13-6. PubMed ID: 7885621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drugs and gastrointestinal disease: pathophysiology, treatment and prevention.
    Bjorkman DJ; Kimmey MB
    Dig Dis; 1995; 13(2):119-29. PubMed ID: 7586632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal antiinflammatory drugs and cyclooxygenase inhibition in the gastrointestinal tract: a trip from peptic ulcer to colon cancer.
    Lanas A
    Am J Med Sci; 2009 Aug; 338(2):96-106. PubMed ID: 19680014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications.
    Lewis JD; Bilker WB; Brensinger C; Farrar JT; Strom BL
    Am J Gastroenterol; 2002 Oct; 97(10):2540-9. PubMed ID: 12385436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat.
    Mahmud T; Somasundaram S; Sigthorsson G; Simpson RJ; Rafi S; Foster R; Tavares IA; Roseth A; Hutt AJ; Jacob M; Pacy J; Scott DL; Wrigglesworth JM; Bjarnason I
    Gut; 1998 Dec; 43(6):775-82. PubMed ID: 9824604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for gastrointestinal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs).
    Agrawal N
    J Fam Pract; 1991 Jun; 32(6):619-24. PubMed ID: 2040888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
    Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
    Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.